Biomedical research at Oslo University Hospital

Publications (original articles or review articles) published in 2019 from OUS - Addiction Treatment Research Units

18 publications found

Arnevik EA, Pedersen G, Walderhaug E, Lien I, Wilberg T, Hummelen B (2019)
Measuring Personality Problems in Patients With Substance Use Disorders: A Cross-Sample Validation
J Dual Diagn, 15 (4), 324-332
DOI 10.1080/15504263.2019.1668583, PubMed 31571533

Bech AB, Clausen T, Waal H, Šaltytė Benth J, Skeie I (2019)
Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study
BMC Health Serv Res, 19 (1), 440
DOI 10.1186/s12913-019-4282-z, PubMed 31266495

Brorson HH, Arnevik EA, Rand K (2019)
Predicting Dropout from Inpatient Substance Use Disorder Treatment: A Prospective Validation Study of the OQ-Analyst
Subst Abuse, 13, 1178221819866181
DOI 10.1177/1178221819866181, PubMed 31452601

Hauger LE, Sagoe D, Vaskinn A, Arnevik EA, Leknes S, Jørstad ML, Bjørnebekk A (2019)
Anabolic androgenic steroid dependence is associated with impaired emotion recognition
Psychopharmacology (Berl), 236 (9), 2667-2676
DOI 10.1007/s00213-019-05239-7, PubMed 30941469

Hauger LE, Westlye LT, Fjell AM, Walhovd KB, Bjørnebekk A (2019)
Structural brain characteristics of anabolic-androgenic steroid dependence in men
Addiction, 114 (8), 1405-1415
DOI 10.1111/add.14629, PubMed 30955206

Havnes IA, Jørstad ML, Wisløff C (2019)
Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
Subst Abuse Treat Prev Policy, 14 (1), 20
DOI 10.1186/s13011-019-0206-5, PubMed 31096999

Helverschou SB, Brunvold AR, Arnevik EA (2019)
Treating Patients With Co-occurring Autism Spectrum Disorder and Substance Use Disorder: A Clinical Explorative Study
Subst Abuse, 13, 1178221819843291
DOI 10.1177/1178221819843291, PubMed 31024216

Latif ZE, Šaltyte Benth J, Solli KK, Opheim A, Kunoe N, Krajci P, Sharma-Haase K, Tanum L (2019)
Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study
JAMA Psychiatry, 76 (2), 127-134
DOI 10.1001/jamapsychiatry.2018.3537, PubMed 30566177

Latif ZE, Solli KK, Opheim A, Kunoe N, Benth JŠ, Krajci P, Sharma-Haase K, Tanum L (2019)
No increased pain among opioid-dependent individuals treated with extended-release naltrexone or buprenorphine-naloxone: A 3-month randomized study and 9-month open-treatment follow-up study
Am J Addict, 28 (2), 77-85
DOI 10.1111/ajad.12859, PubMed 30701613

Muller AE, Bukten A (2019)
Measuring the quality of life of incarcerated individuals
Int J Prison Health, 15 (1), 1-13
DOI 10.1108/IJPH-02-2018-0005, PubMed 30827162

Mørland J, Waal H (2019)
Are intoxicants medication for some?
Tidsskr Nor Laegeforen, 139 (12)
DOI 10.4045/tidsskr.19.0521, PubMed 31502791

Pedersen G, Arnevik EA, Hummelen B, Walderhaug E, Wilberg T (2019)
Psychometric Properties of the Severity Indices of Personality Problems (SIPP) in Two Samples A Norwegian Community Sample and Clinical Samples of Patients With and Without Personality Disorders
Eur. J. Psychol. Assess., 35 (5), 698-711

Pettersen H, Brodahl M, Rundgren J, Davidson L, Havnes IA (2019)
Partnering with persons in long-term recovery from substance use disorder: experiences from a collaborative research project
Harm Reduct J, 16 (1), 40
DOI 10.1186/s12954-019-0310-x, PubMed 31234878

Rognli EB, Bramness JG, von Soest T (2019)
Cannabis use in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, and antidepressants
Acta Psychiatr Scand
DOI 10.1111/acps.13104, PubMed 31560790

Solli KK, Kunoe N, Latif ZE, Sharma-Haase K, Opheim A, Krajci P, Gaulen Z, Šaltytė Benth J, Tanum L (2019)
Availability of Extended-Release Naltrexone May Increase the Number of Opioid-Dependent Individuals in Treatment: Extension of a Randomized Clinical Trial
Eur Addict Res, 25 (6), 303-309
DOI 10.1159/000501931, PubMed 31340204

Sømhovd M, Hagen E, Bergly T, Arnevik EA (2019)
The Montreal Cognitive Assessment as a predictor of dropout from residential substance use disorder treatment
Heliyon, 5 (3), e01282
DOI 10.1016/j.heliyon.2019.e01282, PubMed 31025003

Walderhaug E, Seim-Wikse KJ, Enger A, Milin O (2019)
Polydrug use - prevalence and registration
Tidsskr Nor Laegeforen, 139 (13)
DOI 10.4045/tidsskr.19.0251, PubMed 31556532

Walderhaug E, Seim-Wikse KJ, Enger A, Milin O (2019)
Polydrug Use - prevalence and registration
Tidsskr. Nor. Laegeforen., 139 (13), 1279-1281